Literature DB >> 20205596

Toll-like receptor 4-deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension.

Karen C Young1, Sameh M A Hussein, Rita Dadiz, Daphne deMello, Carlos Devia, Dorothy Hehre, Cleide Suguihara.   

Abstract

Current data suggest that Toll-like receptor 4 (TLR4), a key molecule in the innate immune response, may also be activated following tissue injury. Activation of this receptor is known to induce the production of several proinflammatory cytokines. Given that pulmonary inflammation has been shown to be a key contributor to chronic hypoxia-induced pulmonary vascular remodeling, the authors hypothesized that TLR4-deficient mice would be less susceptible to pulmonary hypertension (PH) as compared to mice with intact TLR4. TLR4-deficient and TLR4-intact strains of inbred mice were exposed to 4, 8, and 16 weeks of hypoxia (0.10 FiO(2)) or normoxia (0.21 FiO(2)) in a normobaric chamber. After chronic hypoxic exposure, TLR4-intact mice developed significant PH evidenced by increased right ventricular systolic pressure, right ventricular hypertrophy, and pulmonary artery medial thickening. In contrast, TLR4-deficient mice had no significant change in any of these parameters and this was associated with decreased pulmonary vascular inflammatory response as compared to the TLR4-intact mice. These results suggest that TLR4 deficiency may decrease the susceptibility to developing PH by attenuating the pulmonary vascular inflammatory response to chronic hypoxia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20205596     DOI: 10.3109/01902140903171610

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  26 in total

1.  Therapeutic Targeting of High-Mobility Group Box-1 in Pulmonary Arterial Hypertension.

Authors:  Neil M Goldenberg; Yijie Hu; Xudong Hu; Allen Volchuk; Yidan D Zhao; Mariya M Kucherenko; Christoph Knosalla; Marc de Perrot; Kevin J Tracey; Yousef Al-Abed; Benjamin E Steinberg; Wolfgang M Kuebler
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

2.  Genetic deletion of toll-like receptor 4 on platelets attenuates experimental pulmonary hypertension.

Authors:  Eileen M Bauer; R Savanh Chanthaphavong; Chhinder P Sodhi; David J Hackam; Timothy R Billiar; Philip M Bauer
Journal:  Circ Res       Date:  2014-03-17       Impact factor: 17.367

Review 3.  Malnutrition, poor post-natal growth, intestinal dysbiosis and the developing lung.

Authors:  Mark A Underwood; Satyan Lakshminrusimha; Robin H Steinhorn; Stephen Wedgwood
Journal:  J Perinatol       Date:  2020-10-14       Impact factor: 2.521

4.  High mobility group Box 1 inhibits human pulmonary artery endothelial cell migration via a Toll-like receptor 4- and interferon response factor 3-dependent mechanism(s).

Authors:  Eileen M Bauer; Richard Shapiro; Timothy R Billiar; Philip M Bauer
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

Review 5.  Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension?

Authors:  Kenia Pedrosa Nunes; Amanda Almeida de Oliveira; Francesca Elisabeth Mowry; Vinicia Campana Biancardi
Journal:  Br J Pharmacol       Date:  2018-08-09       Impact factor: 8.739

6.  Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.

Authors:  Molly K Ball; Gregory B Waypa; Paul T Mungai; Jacqueline M Nielsen; Lyubov Czech; V Joseph Dudley; Lauren Beussink; Robert W Dettman; Sara K Berkelhamer; Robin H Steinhorn; Sanjiv J Shah; Paul T Schumacker
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

Review 7.  Challenges and opportunities in treating inflammation associated with pulmonary hypertension.

Authors:  Norbert F Voelkel; Rasa Tamosiuniene; Mark R Nicolls
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-04

Review 8.  Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders.

Authors:  Hajime Sasaki; Kimito Hirai; Christine M Martins; Hisako Furusho; Ricardo Battaglino; Koshi Hashimoto
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

9.  Direct Extracellular NAMPT Involvement in Pulmonary Hypertension and Vascular Remodeling. Transcriptional Regulation by SOX and HIF-2α.

Authors:  Xiaoguang Sun; Belinda L Sun; Aleksandra Babicheva; Rebecca Vanderpool; Radu C Oita; Nancy Casanova; Haiyang Tang; Akash Gupta; Heather Lynn; Geetanjali Gupta; Franz Rischard; Saad Sammani; Carrie L Kempf; Liliana Moreno-Vinasco; Mohamed Ahmed; Sara M Camp; Jian Wang; Ankit A Desai; Jason X-J Yuan; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2020-07       Impact factor: 6.914

Review 10.  HIV-1, reactive oxygen species, and vascular complications.

Authors:  Kristi M Porter; Roy L Sutliff
Journal:  Free Radic Biol Med       Date:  2012-04-21       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.